Peer Review History
| Original SubmissionAugust 28, 2025 |
|---|
|
Dear Dr. ALQUB, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 17 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Paul H Delano, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please add some discussion about the actual context of Palestine and how it might increase anxiety, insomnia and tinnitus [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: Thank you very much for the opportunity to review this article. I find it highly interesting, and its findings undoubtedly warrant attention from public health policymakers. The assumption of a 50% prevalence for the sample size calculation (which is striking because the prevalence in adults is 30%) is well justified because there were no previous regional data for the specific target population. It is understood that they assumed that tinnitus may have more pronounced risk factors in young people (e.g., exposure to loud music, academic stress levels, etc.). Without specific data for this age group, the researchers took the most rigorous and conservative route from a statistical point of view. The only significant methodological weakness of this study is the use of convenience sampling, which introduces a possible selection bias and prevents the results from being generalised to the entire adolescent population of Palestine. However, this limitation is perfectly managed. The authors justify it due to the difficult conditions for research in the region, openly declare it, and explain its consequences. The ‘Discussion’ section is particularly robust. The authors not only report their findings, but also contextualise them within the global scientific literature, discussing both the evidence that supports them and that which contradicts them. The study is a very good example of rigorous and ethical research in an environment with logistical constraints. Reviewer #2: Thank you for the opportunity to review this manuscript. It represents a commendable effort, and the article is generally well written and clearly communicated. I found it an engaging read. I do, however, have several important observations that I believe the authors should address to further strengthen the work. Most of the concerns regarding this article stem from the limited information provided to evaluate the extent of bias introduced, particularly given the impossibility of randomization in the sample selection. This last consideration is a common issue in some attempts to establish population metrics, and it is well justified in this case in the text. Although the final sample size is more than double the initially estimated target, the risk of substantial bias remains considerable. The authors acknowledge several potential sources of bias in their limitations section; however, they do not provide sufficient data to assess the magnitude of these issues, among others. • Participation bias. The sampling strategy appears to favor individuals with auditory problems, which could significantly distort the representativeness of the findings. This potential bias is not discussed when comparing the results with other studies that may have relied on more representative sampling strategies. • Access-related participation bias. A greater likelihood of participation among individuals with easier access to digital platforms introduces another layer of bias, potentially confounding, in an epidemiological fashion, the reported associations and limiting the external validity of the findings. • Lack of quality control. No procedures are described to verify the identity or characteristics of respondents. While this is a recognized challenge in open surveys, it should be explicitly addressed, particularly given that the study population is narrowly defined in terms of age. • Reflection about the instrument. Although I was not previously familiar with this instrument, it appears to have been widely applied across different settings. However, several methodological aspects require clarification. Was the instrument reverse-translated to ensure linguistic accuracy? Was a pilot study conducted prior to full implementation? In addition, given the length of the questionnaire, how did the authors account for the potential bias arising from respondent fatigue, whereby answers toward the end may be less accurate or consistent? • Survey outreach. An estimation of the total population reached through different recruitment strategies would be valuable for evaluating coverage and representativeness. • Attrition and completion rates. The manuscript does not report the number of participants who completed the survey relative to the number of attempts. It is implausible that all individuals who began the survey completed it. Similarly, it is unclear whether all data fields were fully completed, or whether the survey platform required mandatory responses to proceed. Clarifying this aspect would be essential, as attrition rates and missing data patterns are key indicators of data quality and potential bias. In summary, while the sample size achieved is commendable, the absence of detailed information on recruitment, response validation, and attrition undermines confidence in the robustness and representativeness of the findings. The presentation of results is excessively detailed, which diminishes the reader’s ability to discern the specific contributions of the article. Given that the topic is described as multifactorial and that the supporting evidence for associations with diverse risk factors remains generally weak, the simultaneous testing of a large number of variables is problematic. Moreover, some analyses based on the absence of associations within the dataset are presented but not adequately developed in the discussion. I recommend that the authors streamline their results by emphasizing those factors that appear most compelling or most closely aligned with the evidence introduced in the background, thereby strengthening the coherence and contribution of the manuscript. Related to the previous point and regarding to the limited robustness of the sample, the use of modeling strategies may be problematic. The article would benefit from adopting a more explicitly exploratory tone, consistently avoiding the implication that the findings are representative of the entire population. For example, the results should be systematically framed as applying in “this sample of young Palestinians”, or something similar, rather than presented as generalizable estimates. In this light, the modeling exercises can still be considered valuable, but their contribution should be interpreted as illustrative and exploratory, rather than as evidence of definitive or population-level veracity. There appears to be a systematic error in how prevalence percentages are calculated and communicated. For example, the second paragraph of the Discussion states that girls have a higher prevalence than boys, yet the percentages reported (32.7% and 14.3%) are inconsistent with the tabulated data. Using the authors’ own figures—730 girls in total (Table 1), of whom 370 have tinnitus (Table 6)—the prevalence among girls should be 370/730 ≈ 50.7%, not 32.7%. This suggests the denominator used was the total sample rather than the sex-specific subgroup. Please carefully review all other variables to ensure this error is not repeated, and re-evaluate whether comparisons with external studies remain valid in light of the corrected estimates. Reviewer #3: The partial consideration of tinnitus as a psychosocial symptom is striking, given the context, both in the introduction and the discussion. The allusion to the healthcare costs of the problem is taken out of context and is not revisited in the discussion; it might be better to remove it. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Lorena Rodríguez-Osiac Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Dear Dr. ALQUB, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 15 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Paul H Delano, Ph.D. Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: I’d like to thank the authors for their thoughtful revision of the text. This revised version shows clear effort to improve the manuscript, and several points raised in the initial review have been addressed in a satisfactory manner. I appreciate the clearer acknowledgment of the study’s exploratory nature and tone, the more explicit discussion of limitations related to the sampling strategy, and the expanded description of the questionnaire (i.e. prior validation, pilot testing) Some other comments appear to have been addressed mainly at a declarative level. While additional limitations are now mentioned, their implications are not always incorporated into the interpretation of results or comparisons with other studies. This does not detract substantially from the manuscript. However, I would like to draw attention to one specific issue that remains unresolved and requires further careful revision. Although the authors state that prevalence calculations were corrected, the revised manuscript continues to report sex-specific prevalence percentages using the total sample as the denominator rather than sex-specific denominators. For instance, the proportion of females with tinnitus is still reported as 32.7% (370/1131) in both the abstract and Table 6, whereas the sex-specific prevalence would be approximately 50.7% (370/730), as correctly reflected in the discussion section. While reporting percentages using the total sample as the denominator in a “2×2 table” format can be acceptable if clearly justified and consistently communicated, the use of these percentages in the abstract is potentially misleading. Moreover, when comparing the tables in the revised manuscript with those in the original version, I do not observe any changes to the numerical values. This suggests that, beyond revisiting the calculations in the tables themselves, it is important to carefully review all related interpretations and summaries of the data to ensure consistency and accuracy throughout the manuscript. While this appears to be a technical oversight, correcting it is important, as it affects subgroup comparisons and the interpretation of the findings. I therefore encourage the authors to revisit all prevalence calculations, ensure that appropriate denominators are used throughout, and update any related interpretations accordingly. Overall, the manuscript has improved. and addressing this remaining issue would further strengthen its internal consistency and clarity. Reviewer #3: Two comments regarding the insertions made in the introduction and conclusions, in response to my observations on the first version of the manuscript. (1) Highlighting the greater (but marginal) risk attributed to the age of 17 years is delicate. From a developmental perspective, adolescent development encompasses different classifications; one of the most traditional distinguishes adolescence into early, middle, and late age ranges. The article with which this study is compared and which purportedly supports its findings (ref. 20) compares age ranges (11–14 years and 14–18 years) rather than single-year ages. Moreover, the single-year ages of 15 and 17 years, which are used as points of comparison in the present study, are included within the same age range of middle adolescence from a developmental standpoint, both evolutionarily and in the cited study. This is relevant because the use of age ranges is developmentally grounded in the understanding that adolescents are undergoing continuous development, without absolute thresholds, within a phase of the life cycle that has been relatively understudied and whose upper age limit has been extended (Baird, S., Choonara, S., Azzopardi, P. S., Banati, P., Bessant, J., Biermann, O., Capon, A., Claeson, M., Collins, P. Y., De Wet-Billings, N., Dogra, S., Dong, Y., Francis, K. L., Gebrekristos, L. T., Groves, A. K., Hay, S. I., Imbago-Jácome, D., Jenkins, A. P., Kabiru, C. W., … Viner, R. M. (2025)). In addition, from a technical standpoint, the statistical test applied to the age variable in the present study evaluates the statistical hypothesis of difference versus no difference across the set of ages as a whole, rather than differences between specific single-year ages. (2) Reference 58 acknowledges contextual elements, including collective violence (I suggest review : World Health Organization. (2004). Preventing violence: A guide to implementing the recommendations of the World report on violence and health (ISBN: 9241592079). World Health Organization. Page 1) as a risk factor for PTSD, in which tinnitus would be an associated symptom of a broader clinical condition. In light of this background, I would like to invite the authors to think critically on the investigative, ethical, and epistemic perspective that challenges us all to question the value, energy, and level of detail involved in studying tinnitu as a specific symptom in relation to the adverse childhood experiences (ACEs or Adverse Childhood Events) that adolescents—understood as members of the species in a critical developmental phase that shapes their personal and societal futures—are experiencing in contexts that would make it desirable to consider variables not captured by standardized instruments developed in other settings, as frequently occurs in countries with levels of development different from those considered “developed.” ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Prevalence and Associated Risk Factors of Tinnitus Among Palestinian Adolescents Aged 15–18: A Cross-Sectional Study PONE-D-25-46042R2 Dear Dr. ALQUB, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Paul H Delano, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-46042R2 PLOS One Dear Dr. ALQUB, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Paul H Delano Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .